GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPK

被引:63
|
作者
Aguilar-Recarte, David [1 ,2 ,3 ,4 ]
Barroso, Emma [1 ,2 ,3 ,4 ]
Guma, Anna [2 ,3 ,5 ]
Pizarro-Delgado, Javier [1 ,2 ,3 ,4 ]
Pena, Lucia [1 ,2 ,3 ,4 ]
Ruart, Maria [1 ,2 ,3 ,4 ]
Palomer, Xavier [1 ,2 ,3 ,4 ]
Wahli, Walter [6 ,7 ,8 ]
Vazquez-Carrera, Manuel [1 ,2 ,3 ,4 ]
机构
[1] Univ Barcelona, Fac Pharm & Food Sci, Dept Pharmacol Toxicol & Therapeut Chem, Barcelona 08028, Spain
[2] Univ Barcelona, Inst Biomed Univ Barcelona IBUB, Barcelona 08028, Spain
[3] Inst Salud Carlos III, Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid 28029, Spain
[4] Hosp St Joan de Deu, Pediat Res Inst, Esplugas de Llobregat 08950, Spain
[5] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biomed, Barcelona 08028, Spain
[6] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland
[7] Nanyang Technol Univ Singapore, Lee Kong Chian Sch Med, Singapore 308232, Singapore
[8] INRAE, UMR1331, ToxAlim Res Ctr Food Toxicol, F-31300 Toulouse, France
来源
CELL REPORTS | 2021年 / 36卷 / 06期
关键词
ENDOPLASMIC-RETICULUM STRESS; BETA SUPERFAMILY MEMBER; GROWTH-FACTOR-BETA; INSULIN-RESISTANCE; SKELETAL-MUSCLE; WEIGHT-LOSS; RECEPTOR; P53; EXPRESSION; MICE;
D O I
10.1016/j.celrep.2021.109501
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) activates AMP-activated protein kinase (AMPK) and plays a crucial role in glucose and lipid metabolism. Here, we examine whether PPAR beta/delta activation effects depend on growth differentiation factor 15 (GDF15), a stress response cytokine that regulates energy metabolism. Pharmacological PPAR beta/delta activation increases GDF15 levels and ameliorates glucose intolerance, fatty acid oxidation, endoplasmic reticulum stress, and inflammation, and activates AMPK in HFD-fed mice, whereas these effects are abrogated by the injection of a GDF15 neutralizing antibody and in Gdf15(-/-) mice. The AMPK-p53 pathway is involved in the PPAR beta/delta-mediated increase in GDF15, which in turn activates again AMPK. Consistently, Gdf15(-/-) mice show reduced AMPK activation in skeletal muscle, whereas GDF15 administration results in AMPK activation in this organ. Collectively, these data reveal a mechanism by which PPAR beta/delta activation increases GDF15 levels via AMPK and p53, which in turn mediates the metabolic effects of PPAR beta/delta by sustaining AMPK activation.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] GDF15 is required for maintaining subcutaneous adipose tissue lipid metabolic signature
    Igual-Gil, Carla
    Bishop, Christopher A.
    Jaehnert, Markus
    Johann, Kornelia
    Coleman, Verena
    Baum, Vanessa
    Kruse, Michael
    Pfeiffer, Andreas F. H.
    Pivovarova-Ramich, Olga
    Ost, Mario
    Kleinert, Maximilian
    Klaus, Susanne
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [42] Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15
    Cimino, Irene
    Kim, Hanna
    Tung, Y. C. Loraine
    Pedersen, Kent
    Rimmington, Debra
    Tadross, John A.
    Kohnke, Sara N.
    Neves-Costa, Ana
    Barros, Andre
    Joaquim, Stephanie
    Bennett, Don
    Melvin, Audrey
    Lockhart, Samuel M.
    Rostron, Anthony J.
    Scott, Jonathan
    Liu, Hui
    Burling, Keith
    Barker, Peter
    Clatworthy, Menna R.
    Lee, E-Chiang
    Simpson, A. John
    Yeo, Giles S. H.
    Moita, Luis F.
    Bence, Kendra K.
    Jorgensen, Sebastian Beck
    Coll, Anthony P.
    Breen, Danna M.
    O'Rahilly, Stephen
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (27)
  • [43] Deletion of Gdf15 Reduces ER Stress-induced Beta-cell Apoptosis and Diabetes
    Xu, Guanlan
    Chen, Junqin
    Jo, SeongHo
    Grayson, Truman B.
    Ramanadham, Sasanka
    Koizumi, Akio
    Germain-Lee, Emily L.
    Lee, Se-Jin
    Shalev, Anath
    ENDOCRINOLOGY, 2022, 163 (05)
  • [44] CHOP is dispensable for exercise-induced increases in GDF15
    Townsend, Logan K.
    Medak, Kyle
    Weber, Alyssa J.
    Dibe, Hana
    Shamshoum, Hesham
    Wright, David C.
    JOURNAL OF APPLIED PHYSIOLOGY, 2022, 132 (02) : 413 - 422
  • [45] Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond
    Mullican, Shannon E.
    Rangwala, Shamina M.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2018, 29 (08) : 560 - 570
  • [46] GDF15: a potential therapeutic target for type 1 diabetes
    Sarkar, Soumyadeep
    Melchior, John T.
    Henry, Hayden R.
    Syed, Farooq
    Mirmira, Raghavendra G.
    Nakayasu, Ernesto S.
    Metz, Thomas O.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (01) : 57 - 67
  • [47] GDF15 in Appetite and Exercise: Essential Player or Coincidental Bystander?
    Klein, Anders B.
    Kleinert, Maximilian
    Richter, Erik A.
    Clemmensen, Christoffer
    ENDOCRINOLOGY, 2022, 163 (01)
  • [48] GDF15, an update of the physiological and pathological roles it plays: a review
    Assadi, Artin
    Zahabi, Azadeh
    Hart, Robert A.
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2020, 472 (11): : 1535 - 1546
  • [49] Skeletal muscle mitochondrial dysfunction is associated with increased Gdf15 expression and circulating GDF15 levels in aged mice
    Chen, J.
    Kastroll, J.
    Bello, F. M.
    Pangburn, M. M.
    Murali, A.
    Smith, P. M.
    Rychcik, K.
    Loughridge, K. E.
    Vandevender, A. M.
    Dedousis, N.
    Sipula, I. J.
    Alder, J. K.
    Jurczak, M. J.
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [50] Functional roles of GDF15 in modulating microenvironment to promote carcinogenesis
    Rochette, Luc
    Meloux, Alexandre
    Zeller, Marianne
    Cottin, Yves
    Vergely, Catherine
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (08):